Resting B cells as tolerogens in vivo but only for minor histocompatibility antigens: Evidence for activation of resting B cells in vivo

Transplantation

Volumn 64, Issue 9, 1997, Pages 1330-1335

  Niimi, Masanori ^a   Roelen, Dave L ^a   Wong, Wilson ^a   Hara, Masaki ^a   Morris, Peter J ^a   Wood, Kathryn J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL SURVIVAL; DATA ANALYSIS; FLUORESCENCE ACTIVATED CELL SORTER; GRAFT SURVIVAL; HEART GRAFT; HISTOCOMPATIBILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD86; B-LYMPHOCYTES; FEMALE; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNE TOLERANCE; ISOANTIGENS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; MINOR HISTOCOMPATIBILITY ANTIGENS; SKIN TRANSPLANTATION;

EID: 0030666731     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199711150-00016     Document Type: Article

References (43)

1. Bretscher P, Cohn M. A theory of self-nonself discrimination. Science 1970; 169: 1042.
2. Bretscher P. The two-signal model of lymphocyte activation twenty-one years later. Immunol Today 1992; 13: 74.
3. Schwartz RH. Acquisition of immunologic self-tolerance. Cell 1992; 57: 1073.
4. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993; 11: 191.
5. Lafferty KJ, Prowse SJ, Simeonovic CJ. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol 1983; 1: 143.
6. + T cells. J Exp Med 1991; 173: 759.
7. Linsley P, Brady W, Urnes M, Grosmaire L, Damle N, Ledbetter J. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174: 561.
8. Freeman GJ, Gribben JG, Boussiotis VA, et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993; 262: 909.
9. Azuma M, Ito D, Yagita H, et al. B 70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366: 76.
10. Xu J, Foy TM, Laman JD, et al. Mice deficient for the CD40 ligand. Immunity 1994; 1: 423.
11. Kawabe T, Naka T, Yoshida K, et al. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1994; 1: 167.
12. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992; 356: 607.
13. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248: 1349.
14. Bluestone JA. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 1995; 2: 555.
15. Liu Y, Jones B, Brady W, Janeway CA, Linsley PS. Co-stimulation of murine CD4 T cell growth: cooperation between B7 and heat-stable antigen. Eur J Immunol 1992; 22: 2855.
16. Freedman AS, Freeman GJ, Rhynhart K, Nadler LM. Selective induction of B7/BB1 on interferon gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol 1991; 137: 429.
17. Larsen CP, Ritchie SC, Pearson TC, Linsley PS, Lowry RP. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J Exp Med 1992; 176: 1215.
18. Chen C, Nabavi N. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1994; 1: 147.
19. Finkelman FD, Lees A, Morris SC. Antigen presentation by B lymphocytes to CD4+ T cells in vivo: importance of B lymphocyte and T lymphocyte activation. Semin Immunol 1992; 4: 247.
20. Krieger JI, Grammer SF, Grey HM, Chesnut RW. Antigen presentation by splenic B cells: resting B cells are ineffective, whereas activated B cells are effective accessory cells for T cell response. J Immunol 1985; 135: 2937.
21. Parker DC. T cell-dependent B cell activation. Annu Rev Immunol 1993; 11: 331.
22. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869.
23. Kuchroo VK, Das MP, Brown JA, et al. B7-1 and B7-2 costimulatory molecules activate differently the Th1/Th2 developmental pathway: application to autoimmune disease therapy. Cell 1995; 80: 707.
24. Khoury SJ, Akalin E, Chandraker A, et al. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spare Th2 cytokines in the central nervous system. J Immunol 1995; 155: 4521.
25. Freeman GJ, Boussiotis VA, Anumanthan A, et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995; 2: 523.
26. Fuchs EJ, Matzinger P. B cells turn off virgin but not memory T cells. Science 1992; 258: 1156.
27. Eynon EE, Parker DC. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med 1992; 175: 131.
28. Husbands SD, Schonrich G, Arnold B, et al. Expression of major histocompatibility complex class I antigens at low levels in the thymus induces T cell tolerance via non-deletional mechanism. Eur J Immunol 1992; 22: 2655.
29. Steinman RM, Van Voorhis WC, Spalding DM. Dendritic cells. Handb Exp Immunol 1986; 1.
30. Nabavi N, Freeman GJ, Gault A, Godfrey D, Nadler LM, Glimcher LH. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 1992; 360: 266.
31. Freeman GJ, Borriello F, Hodes RJ, et al. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 1993; 262: 907.
32. Hathcock KS, Laszlo G, Dickler HB, Bradshaw J, Linsley P, Hodes RJ. Identification of an alternative CTLA-4 ligand co-stimulatory for T cell activation. Science 1993; 262: 905.
33. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K and non H-2 antigens in rejection. Transplantation 1973; 16: 343.
34. Superina RA, Peugh WN, Wood KJ, Morris PJ. Assessment of primarily vascularized cardiac allografts in mice. Transplantation 1986; 42: 226.
35. Fable JW, Morris PJ. The effect of donor strain blood pretreatment on renal allograft rejection in rat. Transplantation 1972; 14: 608.
36. Bushell A, Morris PJ, Wood KJ. Induction of operational tolerance by random blood transfusion combined with anti-CD4 antibody therapy. Transplantation 1994; 58: 133.
37. Madsen JC, Supeina RA, Wood KJ. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1988; 332: 161.
38. Wood KJ, Evins J, Morris PJ. Suppression of renal allograft rejection in the rat by class I antigens on purified erythrocytes. Transplantation 1985; 39: 56.
39. Cranston D, Wood KJ, Carter N, Morris PJ. Pretreatment with lymphocyte subpopulations and renal allograft survival in the rat. Transplantation 1987; 43: 809.
40. Niimi M, Rawsthorne M-A, Morris PJ, Wood KJ. B7-2+ low density APCs are as effective as B7-2- small resting B cells in inducing specific unresponsiveness to minor histocompatibility (miH) antigen(s) in vivo. Dendritic Cells Fundamental Clin Immunol 1997; 3: 265.
41. Fu F, Li Y, Qian S, Lu L, et al. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80 dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996; 62: 659.
42. Buhlmann JE, Foy TM, Aruffo AA, et al. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 1995; 2: 645.
43. Parker DC, Greiner DL, Phillips NE, et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 1995; 92: 9560